Patents by Inventor Joel Reid

Joel Reid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silicon substituted oxyapatite
    Patent number: 8029817
    Abstract: The invention is a silicon substituted oxyapatite compound (Si-OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca5(PO4)3-x(SiO4)xO(1-x)/2, where 0<x<1.0.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: October 4, 2011
    Assignee: Warsaw Orthopedic, Inc.
    Inventors: Michael Sayer, Joel Reid, Timothy J. N. Smith, Jason Hendry
  • Silicon substituted oxyapatite
    Patent number: 7498043
    Abstract: The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca5(PO4)3-x(SiO4)xO(1-x)/2, where 0<x<1.0.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: March 3, 2009
    Assignee: Warsaw orthopedic, inc.
    Inventors: Michael Sayer, Joel Reid, Timothy J. N. Smith, Jason Hendry
  • Silicon Substituted Oxyapatite
    Publication number: 20090030089
    Abstract: The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca5(PO4)3-x(SiO4)xO(1-x)/2, where 0<x<1.0.
    Type: Application
    Filed: October 3, 2008
    Publication date: January 29, 2009
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Michael Sayer, Joel Reid, Timothy J.N. Smith, Jason Hendry
  • Metabolites of ecteinascidin 743
    Patent number: 7115743
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: October 3, 2006
    Assignee: Pharma Mar, S.A.
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos
  • Metabolites of ecteinascidin 743
    Publication number: 20050261326
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Application
    Filed: December 10, 2004
    Publication date: November 24, 2005
    Inventors: Kenneth Rinehart, Jose Morales, Joel Reid, Isabel Reymindo, Pablo Floriano, Lola Gravalos
  • Silicon substituted oxyapatite
    Publication number: 20050244449
    Abstract: The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca5(PO4)3-x(SiO4)xO(1-x)/2, where 0<x<1.0.
    Type: Application
    Filed: March 24, 2005
    Publication date: November 3, 2005
    Inventors: Michael Sayer, Joel Reid, Timothy Smith, Jason Hendry
  • Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4
    Patent number: 6867334
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Grant
    Filed: October 3, 2001
    Date of Patent: March 15, 2005
    Assignee: Pharma Mar, S.A.
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos
  • Metabolites of ecteinascidin 743 formed by human cytochrome CYP3A4
    Publication number: 20020032326
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Application
    Filed: October 3, 2001
    Publication date: March 14, 2002
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos
  • ETM-775 metabolite of ecteinascidin 743
    Patent number: 6316214
    Abstract: The purification and structure elucidation of several products of the metabolism of Et 743 by human cytochrome CYP3A4 have been accomplished. These compounds are abbreviated herein as “ETM” followed by a numeric value, which represents the approximate molecular weight. Three compounds have been identified to date, namely ETM 305, ETM 775 and ETM 204.
    Type: Grant
    Filed: May 11, 1999
    Date of Patent: November 13, 2001
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Kenneth L. Rinehart, Jose J. Morales, Joel Reid, Isabel Reymundo, Pablo Floriano, Lola Garcia Gravalos